Bilirubin Blood Test Market: Trends, Growth, and Opportunities

The bilirubin blood test market is on a robust growth path, with a global market size valued at USD 1.23 billion in 2024 and expected to grow to USD 2.09 billion by 2033, registering a CAGR of 6.05%. This growth is fueled by rising cases of liver diseases, neonatal jaundice, and the increasing focus on preventive healthcare worldwide.

📥 Download Sample

What is a Bilirubin Blood Test?

A bilirubin blood test measures bilirubin levels in the blood, a yellow pigment produced when red blood cells break down. Elevated levels may indicate liver diseases like hepatitis or cirrhosis, bile duct issues, or hemolytic anemia. In newborns, this test is crucial for detecting jaundice, preventing complications, and ensuring timely treatment.

Market Highlights

  • Total Serum Bilirubin (TSB) dominates the test-type segment.

  • Hospitals are the leading end-users of bilirubin testing.

  • North America holds the largest market share globally.

Market Trends

The market is witnessing a shift toward non-invasive testing. Devices like transcutaneous bilirubinometers enable painless bilirubin measurement through the skin, reducing infection risk and improving patient comfort, particularly for newborns. Tools like BiliChek™ are transforming hospital practices with faster and safer diagnostics.

Growth Factors

Rising liver diseases and neonatal jaundice drive market demand. According to the WHO, liver diseases cause around 2 million deaths annually, highlighting the need for regular bilirubin monitoring. Nearly 60% of full-term and 80% of preterm infants experience neonatal jaundice, requiring frequent testing to avoid complications.

Market Restraints

High costs of advanced diagnostic equipment, such as transcutaneous bilirubinometers costing USD 3,000–5,000, limit adoption in smaller clinics and resource-constrained regions. Maintenance and skilled operation further add to expenses, restraining market growth.

Market Opportunities

Emerging economies in Asia-Pacific and Latin America present significant growth potential. Investments in healthcare infrastructure, neonatal care, and government initiatives, especially in India and China, are driving increased bilirubin testing. Affordable and accessible solutions can capture this expanding market.

Regional Insights

North America is the largest market, supported by advanced healthcare systems and high liver disease prevalence. In the U.S., around 3,000 babies suffer from severe jaundice annually, driving frequent testing. Asia-Pacific shows rapid growth due to rising birth rates, improved healthcare infrastructure, and government initiatives like China's Healthy China 2030 program.

Test Type Insights

The Total Serum Bilirubin (TSB) segment leads the market, as it is a comprehensive indicator for liver function, neonatal jaundice, and hemolytic disorders. Its inclusion in routine liver function tests and neonatal screenings makes it the preferred choice.

End-User Insights

Hospitals dominate the end-user segment due to high testing volumes, specialized NICUs, and availability of advanced diagnostic devices. Diagnostic laboratories and surgical centers also contribute but at smaller scales.

Key Players

  • Koninklijke Philips N.V.

  • Roche Diagnostics

  • Abbott Laboratories

  • Danaher Corporation

  • AVI Healthcare Pvt. Ltd.

  • Siemens Healthineers

  • Thermo Fisher Scientific

  • Beckman Coulter

  • Ginevri

Recent Developments

  • June 2024: Roche Diagnostics India and MAHE established a Centre of Excellence to foster innovation in diagnostics.

  • January 2024: Roche inaugurated its Digital Centre of Excellence in Pune, enhancing its digital and diagnostic leadership in India.

Analyst Review

The bilirubin blood test market is set for significant expansion, driven by technological advancements, rising preventive healthcare adoption, and growing neonatal and liver disease populations. Companies focusing on non-invasive and AI-driven diagnostics, along with strategic market entry in emerging economies, are expected to capitalize on substantial opportunities.

About Us:

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/

Mehr lesen